This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| KCE (Belgian Health Care Knowledge Centre) | |
|---|---|
| Name | KCE (Belgian Health Care Knowledge Centre) |
| Native name | Centre Fédéral d'Expertise des Soins de Santé |
| Formation | 2003 |
| Headquarters | Brussels |
| Region served | Belgium |
| Leader title | Director |
KCE (Belgian Health Care Knowledge Centre) The KCE is a Belgian public agency established to produce health technology assessment and evidence syntheses to inform decision-making by Belgian institutions such as Federal Public Service Health, Food Chain Safety and Environment, regional authorities like Flemish Government, Walloon Region and international organizations including the European Commission. It operates at the intersection of institutions such as Belgian Health Care Knowledge Centre-adjacent actors, drawing on methods used by organizations like National Institute for Health and Care Excellence, World Health Organization, Organisation for Economic Co-operation and Development, and European Medicines Agency.
KCE was founded in 2003 following policy debates involving stakeholders such as the Belgian Chamber of Representatives, Belgian Senate, and ministries influenced by reports from the High Council of Public Health and comparative studies referencing institutions like Canadian Agency for Drugs and Technologies in Health and Agence Nationale d'Accréditation et d'Évaluation en Santé. Early work responded to pressures from professional bodies including the Belgian Medical Association and patient organizations such as EuroHealthNet. Over time KCE aligned practices with international partners like Health Technology Assessment International and adopted frameworks shared by Cochrane Collaboration and Institute for Clinical and Economic Review.
KCE's mandate was codified through legislation debated in the Belgian Federal Parliament with oversight linked to the Ministry of Public Health (Belgium). Its legal basis situates KCE among statutory bodies alongside agencies such as RIZIV/INAMI and regulatory authorities like Federal Agency for Medicines and Health Products. The statutory framework requires interaction with payers, clinicians represented by organizations like Belgian College of Physicians and patient advocates such as European Patients' Forum, while complying with obligations under EU instruments like directives from the European Parliament and guidance from the Court of Justice of the European Union.
KCE is governed by a board whose composition echoes models used by entities like National Institute for Health and Care Excellence and Swedish Council on Health Technology Assessment, including representatives from ministerial cabinets, professional associations such as the Order of Physicians (Belgium), academic institutions like Katholieke Universiteit Leuven, Université libre de Bruxelles, and Ghent University, and patient groups including Healthcare Consumers' Committee. Operational leadership includes a director supported by divisions comparable to those at Centers for Disease Control and Prevention and Public Health England for methodological work, economic evaluation, and clinical research, with advisory committees engaging experts from institutions such as Université catholique de Louvain and research networks like European Network for Health Technology Assessment.
KCE conducts systematic reviews, health technology assessments, economic evaluations, and pragmatic trials modeled on methods from Cochrane Collaboration, Consolidated Standards of Reporting Trials, and health economics approaches used by International Society for Pharmacoeconomics and Outcomes Research. Its methods draw on epidemiology from sources like European Centre for Disease Prevention and Control, data linkage practices akin to those at Statistics Belgium, and guideline development processes similar to American College of Physicians and National Institute for Health and Care Excellence. KCE collaborates with clinical societies such as Belgian Society of Cardiology, engages registries like Belgian Cancer Registry, and uses real-world data from insurers including RIZIV/INAMI to perform cost-effectiveness analyses and budget impact assessments comparable to those by Institute for Clinical and Economic Review.
KCE publishes assessment reports, methodological guidance, rapid responses, and clinical guidelines, in formats paralleling outputs from NICE guideline, Cochrane Review, and reports by European Observatory on Health Systems and Policies. Its outputs are used by bodies including National Institute for Health and Disability Insurance (Belgium) and cited in deliberations of the Belgian Health Care Knowledge Centre advisory committees, professional associations such as Belgian Society of General Practice, and academic journals like The Lancet and BMJ. KCE also produces datasets and decision tools referenced in conferences organized by Health Technology Assessment International and educational material used by universities like Université de Liège.
KCE's assessments have informed reimbursement decisions by payers such as RIZIV/INAMI, influenced clinical pathways in hospitals like UZ Leuven and Erasme Hospital, and shaped public health initiatives coordinated with Sciensano and regional health authorities including Brussels-Capital Region. Its work has been cited in parliamentary debates at the Belgian Federal Parliament and used by patient organizations like Patients' Federation to advocate for access to interventions evaluated in KCE reports, paralleling impact patterns seen with National Institute for Health and Care Excellence in the United Kingdom.
KCE is funded through public appropriations approved by the Belgian Federal Government and engages in commissioned projects funded by ministries and insurers including RIZIV/INAMI, with partnerships involving academic institutions such as Université libre de Bruxelles, KU Leuven, University of Antwerp and international collaborators like European Commission, World Health Organization, and networks such as European Network for Health Technology Assessment. It participates in EU-funded consortia alongside entities like European Medicines Agency and integrates expertise from research funders including Research Foundation – Flanders and Belgian National Fund for Scientific Research.
Category:Health policy Category:Scientific organisations based in Belgium